Literature DB >> 19407848

In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.

Aki Ishiyama1, Kazuhiko Otoguro, Masato Iwatsuki, Masahito Iwatsuki, Miyuki Namatame, Aki Nishihara, Kenichi Nonaka, Yuta Kinoshita, Yoko Takahashi, Rokuro Masuma, Kazuro Shiomi, Haruki Yamada, Satoshi Omura.   

Abstract

In the course of our screening for antitrypanosomal compounds from soil microorganisms, as well as from the antibiotics library of the Kitasato Institute for Life Sciences, we found three peptide antibiotics, leucinostatin (A and B), alamethicin I and tsushimycin, which exhibited potent or moderate antitrypanosomal activity. We report here the in vitro and in vivo antitrypanosomal properties and cytotoxicities of leucinostatin A and B, alamethicin I and tsushimycin compared with suramin. We also discuss their possible mode of action. This is the first report of in vitro and in vivo trypanocidal activity of leucinostatin A and B, alamethicin I and tsushimycin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407848     DOI: 10.1038/ja.2009.32

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  12 in total

Review 1.  Antimicrobial peptide killing of African trypanosomes.

Authors:  J M Harrington
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

2.  In vitro antitrypanosomal activity of some phenolic compounds from propolis and lactones from Fijian Kawa (Piper methysticum).

Authors:  Kazuhiko Otoguro; Masato Iwatsuki; Aki Ishiyama; Miyuki Namatame; Aki Nishihara-Tsukashima; Hiroaki Kiyohara; Toshihiro Hashimoto; Yoshinori Asakawa; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2011-11-25       Impact factor: 2.343

3.  In vitro antitrypanosomal activity of bis(bibenzyls)s and bibenzyls from liverworts against Trypanosoma brucei.

Authors:  Kazuhiko Otoguro; Aki Ishiyama; Masato Iwatsuki; Miyuki Namatame; Aki Nishihara-Tukashima; Hiroaki Kiyohara; Toshihiro Hashimoto; Yoshinori Asakawa; Satoshi Omura; Haruki Yamada
Journal:  J Nat Med       Date:  2011-09-16       Impact factor: 2.343

4.  Leucinostatins from Ophiocordyceps spp. and Purpureocillium spp. Demonstrate Selective Antiproliferative Effects in Cells Representing the Luminal Androgen Receptor Subtype of Triple Negative Breast Cancer.

Authors:  Yun-Seo Kil; April L Risinger; Cora L Petersen; Susan L Mooberry; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2020-06-08       Impact factor: 4.050

5.  Biosynthesis of Antibiotic Leucinostatins in Bio-control Fungus Purpureocillium lilacinum and Their Inhibition on Phytophthora Revealed by Genome Mining.

Authors:  Gang Wang; Zhiguo Liu; Runmao Lin; Erfeng Li; Zhenchuan Mao; Jian Ling; Yuhong Yang; Wen-Bing Yin; Bingyan Xie
Journal:  PLoS Pathog       Date:  2016-07-14       Impact factor: 6.823

6.  Genome and Transcriptome Sequences Reveal the Specific Parasitism of the Nematophagous Purpureocillium lilacinum 36-1.

Authors:  Jialian Xie; Shaojun Li; Chenmi Mo; Xueqiong Xiao; Deliang Peng; Gaofeng Wang; Yannong Xiao
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

7.  Imidazole and Imidazolium Antibacterial Drugs Derived from Amino Acids.

Authors:  Adriana Valls; Jose J Andreu; Eva Falomir; Santiago V Luis; Elena Atrián-Blasco; Scott G Mitchell; Belén Altava
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-21

Review 8.  Secondary Metabolites of Purpureocilliumlilacinum.

Authors:  Wei Chen; Qiongbo Hu
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

9.  Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.

Authors:  Marta Martínez-García; Jean-Mathieu Bart; Jenny Campos-Salinas; Eva Valdivia; Manuel Martínez-Bueno; Elena González-Rey; Miguel Navarro; Mercedes Maqueda; Rubén Cebrián; José M Pérez-Victoria
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-12       Impact factor: 4.077

Review 10.  Antimicrobial Peptides: a New Frontier in Antifungal Therapy.

Authors:  Giuseppe Buda De Cesare; Shane A Cristy; Danielle A Garsin; Michael C Lorenz
Journal:  mBio       Date:  2020-11-03       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.